Orchestra BioMed Inc. (OBIO) Statistics & Valuation Metrics - Stocknear

Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.75
0.01 (0.36%)
At close: Sep 05, 2025, 3:59 PM
2.73
-0.73%
After-hours: Sep 05, 2025, 04:25 PM EDT

Orchestra BioMed Statistics

Share Statistics

Orchestra BioMed has 53.96M shares outstanding. The number of shares has increased by 1.29% in one year.

53.96M
1.29%
0.79%
49.67%
41.96M
3,885
1.15%

Short Selling Information

The latest short interest is 564.13K, so 1.05% of the outstanding shares have been sold short.

564.13K
1.05%
1.64%
1

Valuation Ratios

The PE ratio is -2.41 and the forward PE ratio is -1.72. Orchestra BioMed's PEG ratio is -0.2.

-2.41
-1.72
55.83
35.8
4.47
-2.9
-0.2
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Orchestra BioMed.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.27, with a Debt / Equity ratio of 0.5.

4.27
4.26
0.5
-0.26
-0.33
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$37.69K
$-871.77K
70
0.03
1.18

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -52.68% in the last 52 weeks. The beta is 0.61, so Orchestra BioMed's price volatility has been higher than the market average.

0.61
-52.68%
2.85
3.89
49.67
338,769

Income Statement

In the last 12 months, Orchestra BioMed had revenue of 2.64M and earned -61.02M in profits. Earnings per share was -1.66.

2.64M
2.43M
-64.3M
-61.02M
-64.3M
-64.3M
-1.66
Full Income Statement

Balance Sheet

The company has 22.26M in cash and 16.53M in debt, giving a net cash position of 5.73M.

22.26M
16.53M
5.73M
-309.88M
42.83M
18.82M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -50.56M and capital expenditures -289K, giving a free cash flow of -50.85M.

-50.56M
-289K
-50.85M
-1.38
Full Cash Flow Statement

Margins

Gross margin is 92.27%, with operating and profit margins of -2437.49% and -2313.27%.

92.27%
-2437.49%
-2313.27%
-2313.27%
-2437.49%
-2437.49%
-1927.48%

Dividends & Yields

OBIO does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for OBIO is $12, which is 338% higher than the current price. The consensus rating is "Buy".

$12
338%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-14.47
3